Abstract: The present invention provides a peptide delivery means capable of avoiding disruption of a cell membrane, immunogenicity, and toxicity. More specifically, the present invention provides the following (1) to (3). (1) A ferritin enclosing a peptide that comprises 3 to 19 amino acid residues and satisfies the following conditions: a) -10.2 = X = 5.9 and 445 = Y = 2524 (where X represents the charge of the peptide at pH 9 and Y represents the chemical formula weight of the peptide). (2) A peptide intracellular delivery agent containing the ferritin enclosing the peptide. (3) A method for producing the ferritin enclosing the peptide.
| # | Name | Date |
|---|---|---|
| 1 | 202247011466.pdf | 2022-03-03 |
| 2 | 202247011466-STATEMENT OF UNDERTAKING (FORM 3) [03-03-2022(online)].pdf | 2022-03-03 |
| 3 | 202247011466-SEQUENCE LISTING(PDF) [03-03-2022(online)].pdf | 2022-03-03 |
| 4 | 202247011466-SEQUENCE LISTING [03-03-2022(online)].txt | 2022-03-03 |
| 5 | 202247011466-PROOF OF RIGHT [03-03-2022(online)].pdf | 2022-03-03 |
| 6 | 202247011466-PRIORITY DOCUMENTS [03-03-2022(online)].pdf | 2022-03-03 |
| 7 | 202247011466-FORM 1 [03-03-2022(online)].pdf | 2022-03-03 |
| 8 | 202247011466-DRAWINGS [03-03-2022(online)].pdf | 2022-03-03 |
| 9 | 202247011466-DECLARATION OF INVENTORSHIP (FORM 5) [03-03-2022(online)].pdf | 2022-03-03 |
| 10 | 202247011466-COMPLETE SPECIFICATION [03-03-2022(online)].pdf | 2022-03-03 |
| 11 | 202247011466-FORM 3 [08-04-2022(online)].pdf | 2022-04-08 |
| 12 | 202247011466-FORM-26 [26-04-2022(online)].pdf | 2022-04-26 |
| 13 | 202247011466-Correspondence_Form1, Power of Attorney_18-11-2022.pdf | 2022-11-18 |
| 14 | 202247011466-FORM 18 [04-08-2023(online)].pdf | 2023-08-04 |
| 15 | 202247011466-RELEVANT DOCUMENTS [14-10-2025(online)].pdf | 2025-10-14 |